51. Non-alcoholic fatty liver disease and its association with incident diabetes in statin-treated individuals. (August 2018) Authors: Barkas, F.; Elisaf, M.; Liberopoulos, E.; Klouras, E.; Kei, A.; Liontos, A.; Megapanou, E.; Lamouri, C.; Rizos, E. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting. A 2-year regional lipid clinic experience. (December 2020) Authors: Anastasiou, G.; Liamis, G.; Milionis, H.; Elisaf, M.; Christopoulou, E.; Dimitriou, T.; Liberopoulos, E. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting. A 3-year regional lipid clinic experience. (August 2021) Authors: Anastasiou, G.; Liamis, G.; Milionis, H.; Elisaf, M.; Christopoulou, E.; Dimitriou, T.; Liberopoulos, E.N. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. Protection against stroke with glucagon‐like peptide 1 receptor agonists: a systematic review and meta‐analysis. (30th January 2019) Authors: Barkas, F.; Elisaf, M.; Milionis, H. Journal: European journal of neurology Issue: Volume 26:Number 4(2019) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. Proton pump inhibitors and statins: a combination that favors ldl-c reduction?. Issue 1 (July 2015) Authors: Barkas, F.; Liberopoulos, E.; Kostapanos, M.; Rizos, C.; Klouras, E.; Elisaf, M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. Proton pump inhibitors and statins: a combination that favors ldl-c reduction?. Issue 1 (July 2015) Authors: Barkas, F.; Liberopoulos, E.; Kostapanos, M.; Rizos, C.; Klouras, E.; Elisaf, M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. Risk of incident diabetes among patients treated with statins ± ezetimibe: Lessons from a lipid clinic after an 8-year follow-up. Issue 1 (July 2015) Authors: Barkas, F.; Rizos, E.; Liberopoulos, E.; Klouras, E.; Elisaf, M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Risk of incident diabetes among patients treated with statins ± ezetimibe: Lessons from a lipid clinic after an 8-year follow-up. Issue 1 (July 2015) Authors: Barkas, F.; Rizos, E.; Liberopoulos, E.; Klouras, E.; Elisaf, M. Journal: Atherosclerosis Issue: Volume 241:Issue 1(2015) Page Start: e223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. Statin escape phenomenon: Does it really exist? Evidence from a lipid clinic. (September 2016) Authors: Barkas, F.; Klouras, E.; Dimitriou, T.; Elisaf, M.; Liberopoulos, E. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
60. Switch to rosuvastatin versus addition of ezetimibe in patients receiving atorvastatin: Effect on urine 8-isoprostane levels. (September 2016) Authors: Klouras, E.; Tellis, C.; Barkas, F.; Liberopoulos, E.; Elisaf, M.; Tselepis, A. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗